Heartware International (NAS: HTWR) reported earnings on Feb. 27. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Heartware International beat expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly. Non-GAAP loss per share contracted. GAAP loss per share stayed the same.
Gross margins dropped, operating margins grew, net margins grew.
Heartware International tallied revenue of $33.2 million. The 14 analysts polled by S&P Capital IQ expected net sales of $29.5 million on the same basis. GAAP reported sales were 42% higher than the prior-year quarter's $23.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$1.46. The 14 earnings estimates compiled by S&P Capital IQ anticipated -$1.65 per share. Non-GAAP EPS were -$1.46 for Q4 against -$1.53 per share for the prior-year quarter. GAAP EPS of -$0.04 were the same as the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 49.2%, 940 basis points worse than the prior-year quarter. Operating margin was -59.3%, much better than the prior-year quarter. Net margin was -64.6%, much better than the prior-year quarter.
Next quarter's average estimate for revenue is $39.6 million. On the bottom line, the average EPS estimate is -$1.11.
Next year's average estimate for revenue is $185.5 million. The average EPS estimate is -$3.53.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 29 members out of 47 rating the stock outperform, and 18 members rating it underperform. Among 15 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), nine give Heartware International a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Heartware International is outperform, with an average price target of $96.71.
Is Heartware International the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
Add Heartware International to My Watchlist.
The article Heartware International Beats on Both Top and Bottom Lines originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.